APOSAN was founded in 1991 with the purpose to service homecare patients through the compounding of individualised infusible and injectable medication. Since then, the company has evolved to an integrated full-range pharmaceutical homecare supplier with its own manufacturing capacities and a dedicated key account management and homecare nurses team to generate and support its growing nationwide patient base.

The APOSAN group of companies is organised in three main business segments: pharmaceutical homecare, providing services to patients that require long-term infusion to diseases; classical homecare, providing standard enteral nutrition solutions as well as selected standard medical devices; and ophthalmic injectables.

APOSAN is headquartered in Cologne, Germany, and serves over 10,000 patients per year.

Value creation strategy
  • Organic growth in existing indications and homecare antibiotic treatments
  • Grow intraveneous product portfolio and further expand into adjacent areas in homecare
Investment history
  • Acquired from the founder October 2016

Press releases
IK Investment Partners has reached an agreement to sell APOSAN to Santé Cie Group
IK Investment Partners to invest in APOSAN
Image to slideshow on startpage: